Summary

A tri-peptide drug for treatment of neurological and neurobehavioral disorders of a mammal, such drug being derived from the following formula: pGlu-X-Pro-NH ₂ , wherein the internal amino acid (X) is a non-histadine amino acid. Methods of treatment of neurological disorders using the tri-peptide, including as an adjunct, synergist or stand-alone therapy, in oral, parenteral, intranasal, transcutaneous, or rectal forms.

Patent Status

Inventors

• Pekary, Albert E.
• Pekary, Albert E.

Contact

UCLA Office of Intellectual Property & Industry Sponsored Research / ncd@research.ucla.edu / tel: View Phone Number. Please reference Tech ID #22315.

Request Additional Information

Other Information

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE TECHNOLOGIES BY OTHER INVENTORS

• Transgenic Mouse Model Of Parkinson's Disease With Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Loss, And Aplha Synuclein...
• Receptor Pathway and Potential Drug Target for Astrocyte Related Disorders of the Nervous System
• New Therapeutic Agents and Novel Drug Delivery Device for Pain Management
• 3D Transurethral Catheter-based Ultrasound System For Multi-modal Fusion in Prostate Imaging
• Diagnostic Markers to Distinguish Between Squamous Cell Carcinoma and Pseudoepitheliomatous Hyperplasia

Search UCLA Research Expertise